Dementia biotech Kinoxis raises $6.75 million with a $2.5m grant as cherry on top
AI Summary
Kinoxis pockets $9.25m to push dementia agitation drugs through trials, with results due in 2027.
Discussion
Sign in to join the discussion.
Loading comments…